Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population

May 1, 2002
Daniel A. Ollendorf, MPH

,
Anna N. Peterson, BA

,
Joseph Doyle, RPh, MBA

,
Daniel M. Huse, MA

Supplements and Featured Publications, Cost and Utilization Analysis for Rheumatoid Arthritis Treatments: An Update for Managed Care, Volume 8, Issue 7 Suppl